Hlk Biotech Holding Stock Probability of Future Pink Sheet Price Finishing Over 2.0E-4
| AMHD Stock | USD 0.0002 0.00 0.00% |
HLK |
HLK Biotech Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of HLK Biotech for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for HLK Biotech Holding can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| HLK Biotech Holding generated a negative expected return over the last 90 days | |
| HLK Biotech Holding has some characteristics of a very speculative penny stock | |
| HLK Biotech Holding has a very high chance of going through financial distress in the upcoming years | |
| HLK Biotech Holding currently holds 600 K in liabilities. HLK Biotech Holding has a current ratio of 0.16, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist HLK Biotech until it has trouble settling it off, either with new capital or with free cash flow. So, HLK Biotech's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like HLK Biotech Holding sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for HLK to invest in growth at high rates of return. When we think about HLK Biotech's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 8.33 K. Net Loss for the year was (3.77 K) with loss before overhead, payroll, taxes, and interest of (180 K). | |
| HLK Biotech Holding currently holds about 185.72 K in cash with (1.21 K) of positive cash flow from operations. |
HLK Biotech Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of HLK Pink Sheet often depends not only on the future outlook of the current and potential HLK Biotech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. HLK Biotech's indicators that are reflective of the short sentiment are summarized in the table below.
HLK Biotech Technical Analysis
HLK Biotech's future price can be derived by breaking down and analyzing its technical indicators over time. HLK Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of HLK Biotech Holding. In general, you should focus on analyzing HLK Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.
HLK Biotech Predictive Forecast Models
HLK Biotech's time-series forecasting models is one of many HLK Biotech's pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary HLK Biotech's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.
Things to note about HLK Biotech Holding
Checking the ongoing alerts about HLK Biotech for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for HLK Biotech Holding help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| HLK Biotech Holding generated a negative expected return over the last 90 days | |
| HLK Biotech Holding has some characteristics of a very speculative penny stock | |
| HLK Biotech Holding has a very high chance of going through financial distress in the upcoming years | |
| HLK Biotech Holding currently holds 600 K in liabilities. HLK Biotech Holding has a current ratio of 0.16, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist HLK Biotech until it has trouble settling it off, either with new capital or with free cash flow. So, HLK Biotech's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like HLK Biotech Holding sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for HLK to invest in growth at high rates of return. When we think about HLK Biotech's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 8.33 K. Net Loss for the year was (3.77 K) with loss before overhead, payroll, taxes, and interest of (180 K). | |
| HLK Biotech Holding currently holds about 185.72 K in cash with (1.21 K) of positive cash flow from operations. |
Other Information on Investing in HLK Pink Sheet
HLK Biotech financial ratios help investors to determine whether HLK Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in HLK with respect to the benefits of owning HLK Biotech security.